avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr2f2
|
ENSMUSG00000030551.7 | nuclear receptor subfamily 2, group F, member 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nr2f2 | mm10_v2_chr7_-_70360593_70360746 | 0.23 | 1.8e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 15.0 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
1.2 | 6.2 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
1.1 | 3.3 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
1.1 | 3.3 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.9 | 6.5 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.8 | 5.9 | GO:0006108 | malate metabolic process(GO:0006108) |
0.8 | 2.5 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.8 | 11.5 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.8 | 17.7 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.7 | 3.3 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.6 | 2.5 | GO:0055071 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.6 | 1.9 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) |
0.6 | 1.9 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
0.5 | 2.5 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.5 | 1.9 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.5 | 3.7 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.5 | 1.8 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.4 | 1.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.4 | 2.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.4 | 1.2 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.4 | 2.7 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.4 | 1.1 | GO:1903537 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.4 | 2.2 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.4 | 1.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.4 | 2.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.4 | 2.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.3 | 1.3 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.3 | 2.2 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.3 | 1.3 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.3 | 0.9 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
0.3 | 2.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.3 | 1.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.3 | 1.7 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.3 | 1.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 0.8 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.3 | 0.8 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 0.8 | GO:1902277 | negative regulation of pancreatic amylase secretion(GO:1902277) |
0.2 | 3.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 0.7 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.2 | 2.8 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.7 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.2 | 3.9 | GO:0051608 | histamine transport(GO:0051608) |
0.2 | 1.3 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.2 | 2.9 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 0.4 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.2 | 0.6 | GO:0007172 | signal complex assembly(GO:0007172) regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.2 | 1.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 1.5 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 0.6 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.2 | 0.6 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.2 | 1.6 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.2 | 0.8 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 0.8 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 0.8 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.2 | 1.7 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 0.9 | GO:0021564 | vagus nerve development(GO:0021564) |
0.2 | 1.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 0.4 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.2 | 0.7 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.2 | 4.8 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.2 | 1.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 1.7 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 1.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 2.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 0.6 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 0.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 0.8 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.2 | 2.0 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 0.6 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.2 | 0.8 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 1.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 1.0 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.4 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.1 | 0.4 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.6 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.4 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.1 | 1.1 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.1 | 0.4 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.1 | 1.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 1.9 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 3.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 4.0 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 2.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.7 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 0.9 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 3.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.5 | GO:0055099 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) response to high density lipoprotein particle(GO:0055099) |
0.1 | 0.6 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.1 | 0.7 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.5 | GO:1900175 | regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.1 | 0.8 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 0.5 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.7 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.9 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 1.8 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.4 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.4 | GO:0048382 | mesendoderm development(GO:0048382) |
0.1 | 1.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.3 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.1 | 0.6 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.3 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.7 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 3.6 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.5 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.1 | 0.6 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 0.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.1 | 0.3 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.7 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 3.4 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.8 | GO:1903350 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.1 | 0.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 1.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 4.5 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.7 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.6 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.1 | 0.5 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 3.0 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 3.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.9 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.4 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 1.0 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 1.3 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 3.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 1.5 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 1.3 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.0 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.6 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 4.4 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.0 | 0.6 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 1.7 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.0 | 1.3 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.1 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) positive regulation of maintenance of sister chromatid cohesion(GO:0034093) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.0 | 0.6 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.7 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 1.8 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.3 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.0 | 2.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 2.9 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.2 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.0 | 0.7 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 1.2 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.5 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.6 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.2 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.0 | 0.6 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.7 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 1.4 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 1.6 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.5 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 2.4 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 1.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 1.1 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) receptor localization to synapse(GO:0097120) |
0.0 | 0.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.0 | 0.4 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 1.0 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 1.8 | GO:0006818 | hydrogen transport(GO:0006818) |
0.0 | 0.8 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.3 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.1 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
0.0 | 2.3 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.0 | 0.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.6 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.1 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.0 | 0.7 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 0.3 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.0 | 0.0 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 1.2 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.6 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 1.2 | GO:0006334 | nucleosome assembly(GO:0006334) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 15.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.0 | 2.9 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.5 | 2.9 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.4 | 1.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.4 | 1.5 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
0.3 | 2.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 1.8 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.3 | 1.2 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.3 | 0.8 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.2 | 1.5 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.2 | 2.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 1.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 4.0 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.2 | 1.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.2 | 1.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 3.3 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 0.8 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 6.5 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 1.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 1.1 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.2 | 1.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 3.7 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 4.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.8 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.6 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 1.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 1.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 1.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.9 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.6 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.5 | GO:0032444 | activin responsive factor complex(GO:0032444) SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 4.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.5 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 1.3 | GO:0044754 | autolysosome(GO:0044754) |
0.1 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 2.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 1.4 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 1.0 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 1.1 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 1.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 1.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 1.1 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.1 | 0.6 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 4.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.0 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 3.2 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 1.9 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.5 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 16.9 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.2 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 1.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.7 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 0.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 1.7 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 2.1 | GO:0044439 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.0 | 0.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 5.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 2.5 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 2.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 1.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 1.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 2.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 1.8 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.5 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 4.3 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 2.5 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 1.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 2.0 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.2 | GO:0030663 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
0.0 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 2.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.9 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 1.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.4 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.7 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
1.1 | 6.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
1.0 | 11.5 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.8 | 3.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.8 | 15.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.7 | 5.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.7 | 2.0 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.6 | 2.5 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.6 | 1.9 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
0.6 | 2.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.5 | 2.8 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.5 | 1.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 1.3 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.4 | 1.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.4 | 1.1 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.4 | 2.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.4 | 1.1 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.4 | 2.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 4.3 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 1.8 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.3 | 3.3 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.3 | 1.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.3 | 1.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 6.2 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 1.0 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
0.2 | 1.7 | GO:0008312 | signal recognition particle binding(GO:0005047) 7S RNA binding(GO:0008312) |
0.2 | 0.9 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.2 | 1.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 0.6 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 4.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 0.8 | GO:0019809 | spermidine binding(GO:0019809) |
0.2 | 1.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 1.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 1.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 0.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.2 | 1.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 1.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 4.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 0.8 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 0.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 1.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 2.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.4 | GO:0070546 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 0.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.7 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.7 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.7 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.1 | 0.8 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.4 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.1 | 1.6 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.4 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.1 | 0.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.8 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 1.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.6 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 1.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 2.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 1.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 1.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 1.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.5 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 0.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 2.8 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 4.2 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 1.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 19.3 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 1.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.9 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 1.3 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 1.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.7 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 1.7 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 3.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 1.8 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 3.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 1.6 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.4 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 2.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 1.8 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 3.1 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.7 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 8.2 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 3.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 1.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 1.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 1.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.1 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.0 | 1.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 1.0 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 1.7 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 1.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.1 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.0 | 0.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 3.2 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.4 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 1.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 1.5 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.3 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 1.0 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.1 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
0.0 | 0.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.8 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 3.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 1.6 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 1.9 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.3 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 3.3 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 1.1 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 1.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 1.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 1.8 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.0 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.1 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.0 | 1.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 3.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 2.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 5.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 2.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 1.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 1.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 1.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 2.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 1.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 1.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 1.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 2.7 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 1.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 1.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 3.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.6 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.5 | PID LKB1 PATHWAY | LKB1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 4.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 4.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 2.7 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.2 | 2.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 2.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 3.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 3.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 2.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 3.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 2.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 3.0 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 6.4 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 4.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 2.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 2.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 3.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 6.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 3.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 3.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 2.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 1.0 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.3 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.5 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 1.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 1.8 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 2.8 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 1.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 2.0 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 1.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 1.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 1.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |